1. Home
  2. TELO vs CATO Comparison

TELO vs CATO Comparison

Compare TELO & CATO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TELO
  • CATO
  • Stock Information
  • Founded
  • TELO 2021
  • CATO 1946
  • Country
  • TELO United States
  • CATO United States
  • Employees
  • TELO N/A
  • CATO N/A
  • Industry
  • TELO
  • CATO Clothing/Shoe/Accessory Stores
  • Sector
  • TELO
  • CATO Consumer Discretionary
  • Exchange
  • TELO NYSE
  • CATO Nasdaq
  • Market Cap
  • TELO 52.4M
  • CATO 57.6M
  • IPO Year
  • TELO 2024
  • CATO N/A
  • Fundamental
  • Price
  • TELO $2.19
  • CATO $3.04
  • Analyst Decision
  • TELO
  • CATO
  • Analyst Count
  • TELO 0
  • CATO 0
  • Target Price
  • TELO N/A
  • CATO N/A
  • AVG Volume (30 Days)
  • TELO 9.2M
  • CATO 30.4K
  • Earning Date
  • TELO 08-12-2025
  • CATO 08-21-2025
  • Dividend Yield
  • TELO N/A
  • CATO 5.52%
  • EPS Growth
  • TELO N/A
  • CATO N/A
  • EPS
  • TELO N/A
  • CATO N/A
  • Revenue
  • TELO N/A
  • CATO $642,949,000.00
  • Revenue This Year
  • TELO N/A
  • CATO N/A
  • Revenue Next Year
  • TELO N/A
  • CATO N/A
  • P/E Ratio
  • TELO N/A
  • CATO N/A
  • Revenue Growth
  • TELO N/A
  • CATO N/A
  • 52 Week Low
  • TELO $1.12
  • CATO $2.19
  • 52 Week High
  • TELO $8.40
  • CATO $6.70
  • Technical
  • Relative Strength Index (RSI)
  • TELO 64.07
  • CATO 54.61
  • Support Level
  • TELO $2.00
  • CATO $2.76
  • Resistance Level
  • TELO $2.44
  • CATO $3.07
  • Average True Range (ATR)
  • TELO 0.19
  • CATO 0.18
  • MACD
  • TELO 0.15
  • CATO 0.01
  • Stochastic Oscillator
  • TELO 54.04
  • CATO 62.22

About TELO TELOMIR PHARMACEUTICALS INC

Telomir Pharmaceuticals Inc is a pioneering preclinical-stage pharmaceutical company which leads the advancement of age-reversal science. The Company is focused on developing Telomir-1, a novel small molecule designed to lengthen and protect telomeres-the protective DNA end caps of chromosomes that are crucial to cellular aging. As humans and animals age, telomeres naturally shorten, with metal reactivity accelerating this process, increasing the risk of degenerative and age-related diseases. By addressing the underlying causes of aging at the cellular level, Telomir aims to tackle the root of these conditions rather than simply treating their symptoms. Telomir is conducting ongoing preclinical research into Progeria, diabetes, cancer, Alzheimer's disease, osteoarthritis, and others.

About CATO Cato Corporation (The)

The Cato Corp operates as a specialty retailer of fashion apparel and accessories in the southeastern United States. Its primary objective is to be the fashion specialty retailer for fashion and value in its markets. The company operates through the following business segments: Retail and Credit. The Retail segment which generates the majority of revenue offers fashion specialty stores. The Credit segment involves credit card services.

Share on Social Networks: